```

[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[S. 2046 Introduced in Senate (IS)]

103d CONGRESS
  2d Session
                                S. 2046

To amend the Public Health Service Act to provide for the establishment 
  by the National Institutes of Health of research centers regarding 
              movement disorders, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

               April 26 (legislative day, April 11), 1994

  Mr. Cochran introduced the following bill; which was read twice and 
         referred to the Committee on Labor and Human Resources

_______________________________________________________________________

                                 A BILL

 
To amend the Public Health Service Act to provide for the establishment 
  by the National Institutes of Health of research centers regarding 
              movement disorders, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Movement Disorders Research 
Amendments of 1993''.

SEC. 2. ESTABLISHMENT OF AUTHORITY FOR RESEARCH CENTERS REGARDING 
              MOVEMENT DISORDERS.

    Part B of title IV of the Public Health Service Act (42 U.S.C. 284 
et seq.), as amended by section 302 of Public Law 103-43 (107 Stat. 
151), is amended by inserting after section 409A the following new 
section:

            ``research centers regarding movement disorders

    ``Sec. 409B. (a) The Director of NIH, acting through the Directors 
of the appropriate national research institutes and after consultation 
with the advisory councils for such institutes, may make grants to, or 
enter into contracts with, public or nonprofit private entities for the 
development and operation of centers to conduct basic and clinical 
research on movement disorders, including but not limited to the 
conditions specified in subsection (b).
    ``(b) The conditions specified in this subsection are as follows:
            ``(1) Various dystonias, including blepharospasm, spasmodic 
        dysphonia, spasmodic torticollis, and Meige syndrome.
            ``(2) Huntington's disease and other choreas, including 
        sydenham chorea, senile chorea, and tardive dyskinesia.
            ``(3) Myoclonus, Parkinson's disease, progressive 
        supranuclear palsy, Rett syndrome, Shy-Drager syndrome, tics 
        and tourette syndrome, essential tremor, and Wilson's disease.
    ``(c) Each center assisted under this section shall use the 
facilities of a single institution, or be formed from a consortium of 
cooperating institutions, meeting such requirements as may be 
prescribed by the Director of NIH.
    ``(d) Support of a center under this section may be for a period 
not exceeding 5 years. Such period may be extended for one or more 
additional periods not exceeding 5 years if the operations of such 
center have been reviewed by an appropriate technical and scientific 
peer review group established by the Director of NIH and if such group 
has recommended to the Director that such period should be extended.
    ``(e) No amounts are authorized to be appropriated under this 
section. This section may be carried out only with amounts that are 
otherwise appropriated for activities of the National Institutes of 
Health and that, as provided in appropriations Acts, are available for 
the grants and contracts described in subsection (a).''.

                                 <all>
```